PeptideDB

fStAx-35R TFA

CAS: F: C136H198N42O27S.xC2HF2O2 W: 2885.36 (free base)

fStAx-35R TFA is the hydrocarbon-stapled peptide. fStAx-35R TFA inhibits Wnt/β-catenin signaling pathway by disrupting
Sales Email：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity fStAx-35R TFA is the hydrocarbon-stapled peptide. fStAx-35R TFA inhibits Wnt/β-catenin signaling pathway by disrupting the β-catenin-TCF interaction. fStAx-35R TFA can be used in cancer research[1].
Shortening FITC-PEG1-RRWPR-S5-ILD-S5-HVRRVWR-NH2
Formula C136H198N42O27S.xC2HF2O2
Molar Mass 2885.36 (free base)
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Reference [1]. Cui HK, et al., Design of stapled α-helical peptides to specifically activate Wnt/β-catenin signaling. Cell Res. 2013 Apr;23(4):581-4.

21-Angeloyl-protoaescigenin

ML171 analog 1

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.